KRYSTAL BIOTECH INC. - COMMON STOCK
187.86
21-February-25 15:45:00
15 minutes delayed
Stocks
+5.24
+2.87%
Today's range
184.12 - 189.19
ISIN
N/A
Source
NASDAQ
-
18 Jan 2022 06:00:01 By Nasdaq GlobeNewswire
-
Krystal Biotech Announces Pricing of $200 Million Public Offering of Common Stock
30 Nov 2021 19:15:00 By Nasdaq GlobeNewswire
-
Krystal Biotech Announces Proposed $200 Million Public Offering of Common Stock
29 Nov 2021 15:20:00 By Nasdaq GlobeNewswire
-
29 Nov 2021 06:00:00 By Nasdaq GlobeNewswire
-
08 Nov 2021 06:00:01 By Nasdaq GlobeNewswire
-
26 Oct 2021 06:00:00 By Nasdaq GlobeNewswire
-
19 Oct 2021 15:05:00 By Nasdaq GlobeNewswire
-
14 Oct 2021 06:00:00 By Nasdaq GlobeNewswire
-
12 Oct 2021 07:00:02 By Nasdaq GlobeNewswire
-
Krystal Biotech to Present at the Chardan 5th Annual Genetic Medicines Conference
01 Oct 2021 15:01:00 By Nasdaq GlobeNewswire
-
29 Sep 2021 07:00:01 By Nasdaq GlobeNewswire
-
Krystal Biotech Appoints Laurent Goux as General Manager of Europe
15 Sep 2021 07:00:01 By Nasdaq GlobeNewswire
-
Krystal Biotech to Present Data on DEB and B-VEC at the DEBRA International Conference 2021
09 Sep 2021 07:00:02 By Nasdaq GlobeNewswire
-
Krystal Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
07 Sep 2021 15:31:00 By Nasdaq GlobeNewswire
-
09 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
01 Jul 2021 15:15:00 By Nasdaq GlobeNewswire
-
Krystal Biotech to Participate in Upcoming Investor Conferences
03 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
10 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
Krystal Biotech Appoints Andy Orth as Chief Commercial Officer
03 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
27 Apr 2021 15:35:00 By Nasdaq GlobeNewswire